Interested in the latest advancements in protein and antibody engineering? Join us next week in Boston at #PEGS2024, booth 715, for an in-depth discussion about our flexible solutions for complex biologics. Our Head of Process Development, Dr. Xiaofeng (Kevin) Han, will be presenting some exciting updates in the poster titled "ATF N-1/N Stage Perfusion Platform Process Development Using mAb Producing CHO Cell Culture.". #processdevelopment #innovation #biomanufacturing #californiabusiness #CDMO
JOINN Biologics US Inc.’s Post
More Relevant Posts
-
Register today for "An Advanced and Highly Flexible Single B Cell Technology Platform for Antibody Discovery" Single B cell screening is an emerging technology for antibody discovery. The platform is ideal because it allows researchers to discover physiologically relevant therapeutic mAbs from any species without significant investment. In this presentation, Jieying will introduce a fast, ultra-high throughput and highly versatile, single B cell platform developed by WuXi Biologics that overcomes many of the limitations of traditional antibody discovery platforms. The webinar will showcase several case studies on the discovery of antibodies to various targets using the single B cell screening technology. Register today: https://lnkd.in/dFgEY7r7 #antibodyengineering #singlebcell #antibodydiscovery #antibodydevelopment #drugdiscovery #singlebcellcloning #AETdigitalweek
To view or add a comment, sign in
-
Register today for "An Advanced and Highly Flexible Single B Cell Technology Platform for Antibody Discovery" Single B cell screening is an emerging technology for antibody discovery. The platform is ideal because it allows researchers to discover physiologically relevant therapeutic mAbs from any species without significant investment. In this presentation, Jieying will introduce a fast, ultra-high throughput and highly versatile, single B cell platform developed by WuXi Biologics that overcomes many of the limitations of traditional antibody discovery platforms. The webinar will showcase several case studies on the discovery of antibodies to various targets using the single B cell screening technology. Register today: https://lnkd.in/dFgEY7r7 #antibodyengineering #singlebcell #antibodydiscovery #antibodydevelopment #drugdiscovery #singlebcellcloning #AETdigitalweek
To view or add a comment, sign in
-
In Case You Missed it "An Advanced and Highly Flexible Single B Cell Technology Platform for Antibody Discovery" Single B cell screening is an emerging technology for antibody discovery. The platform is ideal because it allows researchers to discover physiologically relevant therapeutic mAbs from any species without significant investment. In this presentation, Jieying will introduce a fast, ultra-high throughput and highly versatile, single B cell platform developed by WuXi Biologics that overcomes many of the limitations of traditional antibody discovery platforms. The webinar will showcase several case studies on the discovery of antibodies to various targets using the single B cell screening technology. On Demand: https://lnkd.in/eFSvxVfq #antibodyengineering #singlebcell #antibodydiscovery #antibodydevelopment #drugdiscovery #singlebcellcloning #AETdigitalweek
To view or add a comment, sign in
-
In Case You Missed It! Our Biologics Innovation Discovery team featured a new scientific poster during the recent Antibody Engineering & Therapeutics Conference. "Developability Assessment and Optimization of Antibodies and Antibody-derived Molecules at Early-Stage Discovery" shares how asssessment of developability at the early discovery stage should be performed in a rapid and high-throughput manner while consuming small amounts of testing materials. Our scientists showcase several case studies regarding significant improvement of stability, solubility, specificity, homogeneity and pharmacokinetics of antibody related candidates. View the full poster here: https://lnkd.in/eeufdxnX #developability #drugdiscovery #drugdevelopment #antibodydiscovery
To view or add a comment, sign in
-
In Case You Missed It! Our Biologics Innovation Discovery team featured a new scientific poster during the recent Antibody Engineering & Therapeutics Conference. "Developability Assessment and Optimization of Antibodies and Antibody-derived Molecules at Early-Stage Discovery" shares how asssessment of developability at the early discovery stage should be performed in a rapid and high-throughput manner while consuming small amounts of testing materials. Our scientists showcase several case studies regarding significant improvement of stability, solubility, specificity, homogeneity and pharmacokinetics of antibody related candidates. View the full poster here: https://lnkd.in/eeufdxnX #developability #drugdiscovery #drugdevelopment #antibodydiscovery
To view or add a comment, sign in
-
Register today for "An Advanced and Highly Flexible Single B Cell Technology Platform for Antibody Discovery" Single B cell screening is an emerging technology for antibody discovery. The platform is ideal because it allows researchers to discover physiologically relevant therapeutic mAbs from any species without significant investment. In this presentation, Jieying will introduce a fast, ultra-high throughput and highly versatile, single B cell platform developed by WuXi Biologics that overcomes many of the limitations of traditional antibody discovery platforms. The webinar will showcase several case studies on the discovery of antibodies to various targets using the single B cell screening technology. Register today: https://lnkd.in/dFgEY7r7 #antibodyengineering #singlebcell #antibodydiscovery #antibodydevelopment #drugdiscovery #singlebcellcloning #AETdigitalweek
To view or add a comment, sign in
-
In case you missed our latested webinar: "An Advanced and Highly Flexible Single B Cell Technology Platform for Antibody Discovery." Single B cell screening is an emerging technology for antibody discovery. The platform is ideal because it allows researchers to discover physiologically relevant therapeutic mAbs from any species without significant investment. In this presentation, Jieying introduces a fast, ultra-high throughput and highly versatile, single B cell platform developed by WuXi Biologics that overcomes many of the limitations of traditional antibody discovery platforms. The webinar showcases several case studies on the discovery of antibodies to various targets using the single B cell screening technology. Watch today: https://lnkd.in/eFSvxVfq #antibodyengineering #singlebcell #antibodydiscovery #antibodydevelopment #drugdiscovery #singlebcellcloning #AETdigitalweek
To view or add a comment, sign in
-
In case you missed our latested webinar: "An Advanced and Highly Flexible Single B Cell Technology Platform for Antibody Discovery." Single B cell screening is an emerging technology for antibody discovery. The platform is ideal because it allows researchers to discover physiologically relevant therapeutic mAbs from any species without significant investment. In this presentation, Jieying introduces a fast, ultra-high throughput and highly versatile, single B cell platform developed by WuXi Biologics that overcomes many of the limitations of traditional antibody discovery platforms. The webinar showcases several case studies on the discovery of antibodies to various targets using the single B cell screening technology. Watch today: https://lnkd.in/eFSvxVfq #antibodyengineering #singlebcell #antibodydiscovery #antibodydevelopment #drugdiscovery #singlebcellcloning #AETdigitalweek
To view or add a comment, sign in
-
In Case You Missed It! Our Biologics Innovation Discovery team featured a new scientific poster during the recent Antibody Engineering & Therapeutics Conference. "Developability Assessment and Optimization of Antibodies and Antibody-derived Molecules at Early-Stage Discovery" shares how asssessment of developability at the early discovery stage should be performed in a rapid and high-throughput manner while consuming small amounts of testing materials. Our scientists showcase several case studies regarding significant improvement of stability, solubility, specificity, homogeneity and pharmacokinetics of antibody related candidates. View the full poster here: https://lnkd.in/eeufdxnX #developability #drugdiscovery #drugdevelopment #antibodydiscovery
To view or add a comment, sign in
-
evitria’s journal club - paper of the week no. 12 Antibody Structure and Function: The Basis for Engineering Therapeutics by Mark Chiu et al. Dive into the intricate details of antibody structure and engineering with this comprehensive review! Explore the foundational knowledge of antibody architecture and the innovative strategies for creating therapeutic biologics. From the development of antibodies, fragments, bispecifics, and fusions, to the enhancement of affinity, stability, and effector functions, this paper is a treasure trove for those passionate about protein engineering and therapeutic applications. 🧬🔬 Want to learn more about how evitria can support your biologics development work? Get in touch today: www.evitria.com/contact #antibodies #research #proteinengineering
To view or add a comment, sign in
2,198 followers